AACR 2024: Some Clinical Readouts 📖
#AACR24
⇨ Starts this Friday (4/5 - 4/10) 🗓️
⇨ One of the top cancer biomed meetings
◦ Historically pre-clin presentations
◦ but,
◦ now some clinical presentations too
⇨ Of course, the big cancer biomed meeting is ASCO
◦ #ASCO24 coming later this quarter 😮
⇨ See below for some #AACR24 clinical readouts
◦ From our catalyst calendar
👀 See below how to get access to our full catalyst calendar!
AACR 2024: Some Clinical Readouts 👇
4/7
$REPL (RP1) Ph 1/2 - Cutaneous squamous cell carcinoma
$KZIA (EVT801) Ph 1 - Advanced Solid Tumors
4/8
$PSTX (P-BCMA-ALLO1) Ph 1/2 - Multiple Myeloma
4/9
$BGNE (Ociperlimab + tislelizumab) Ph 2 - limited-stage-SCLC
$MDNA (MDNA1) Ph 1/2 - Cold Tumors
$RAPT (Tivumecirnon) Ph 2 - Solid Tumors (NSCLC)
$FUSN (FPI-2265) Ph 2 - Prostate Cancer
$PPBT (NT219) Ph 1 - SCCHN
$ATOS ((Z)-endoxifen) Ph 2 - Breast Cancer
4/10
$LTRN (LP-284) Ph 1 - Non-Hodgkin's Lymphoma
$BNTX (BNT116 +/- cemiplimab) Ph 1 - NSCLC
See image for more info. 📸 👇
Sign up for BPIQ Elite today!
🚨 40% off AACR sale ends soon
💡 Data/tools to enhance your bio investing:
⇨ Big Mover stocks to watch
⇨ PDUFA & Catalyst Calendars
⇨ Model Portfolios
• Hedge fund favorites
• Run-Up Plays
Stay on top of your bio investing with our tools!
Click the link 👉 🔗 AACR sale!
This article is not investment or legal advice.
Article history:
4/3/24 EJV & AV
#REPL #KZIA #PSTX #BGNE #MDNA #RAPT #FUSN #PPBT #ATOS #LTRN #BNTX